歡迎光臨源葉生物,登錄 | 注冊(cè) |
當(dāng)前位置: 首頁(yè) > 小分子抑制劑 > PI3K/Akt/mTORsignaling > BEZ235 (Tosylate)

瀏覽歷史

S81732

BEZ235 (Tosylate)

源葉(MedMol) 99%
  • 英文名:
  • BEZ235 (Tosylate)
  • 別名:
  • BEZ235 Tosylate||BEZ-235 Tosylate; NVP-BEZ235 tosylate; NVP-BEZ235-ANA; 2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile monotosylate; Dacto
  • CAS號(hào):
  • 1028385-32-1
  • 分子式:
  • C37H31N5O4S
  • 分子量:
  • 641.7382
品牌貨號(hào)產(chǎn)品規(guī)格價(jià)格(RMB) 庫(kù)存(上海) 北京 武漢 南京 數(shù)量計(jì)量單位 加入購(gòu)物車(chē)...
源葉(MedMol) S81732-10mg 99% ¥410.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S81732-50mg 99% ¥880.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S81732-100mg 99% ¥1400.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
源葉(MedMol) S81732-500mg 99% ¥3900.00元 預(yù)計(jì)交期:2-3天 - - - EA 加入購(gòu)物車(chē)
大包裝詢(xún)價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(1篇)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

  • 提示:詳情請(qǐng)下載說(shuō)明書(shū)。
  • 產(chǎn)品描述: Dactolisib Tosylate (BEZ235 Tosylate) is a dual PI3K and mTOR kinase inhibitor with IC50 values of 4, 75, 7, 5 nM for PI3Kα, β, γ, δ, respectively. Dactolisib Tosylate (BEZ235 Tosylate) inhibits mTORC1 and mTORC2
  • 靶點(diǎn): p110α:4 nM (IC50);p110α-H1047R:4.6 nM (IC50);p110α-E545K:5.7 nM (IC50);p110γ:5 nM (IC50);p110δ;7 nM (IC50);p110β:75 nM (IC50);mTOR:20.7 nM (IC50);mTORC1;mTORC2;Autophagy;PI3K;?mTOR
  • 體外研究:
    Dactolisib (BEZ235) is an imidazo[4,5-c]quinoline derivative that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. The IC50s for PI3Kα, β, γ, δ are 4, 75, 7, 5 nM, respectively. It is also found to be as active against the mutant PI3KαE545K or PI3KαH1047R with IC50s of 5.7 and 4.6 nM, respectively. In human tumor cell lines, it is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest. PTEN-null cell lines PC3M and U87MG shows a dose-dependent reduction in cell proliferation when treated with increasing concentrations of Dactolisib (BEZ235), with an average GI50 of 10 to 12 nM
  • 體內(nèi)研究:
    Dactolisib (BEZ235) is well tolerated, displays disease stasis when administered orally, and enhances the efficacy of other anticancer agents. At a dose of 50 mg/kg, Dactolisib (BEZ235) appears rapidly in plasma with a Cmax of 1.68 μM at 0.5 h and a C24h of 0.03 μM
  • 參考文獻(xiàn):
    1. Maira SM, et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther, 2008, 7(7), 1851-1863.
  • 溶解性: soluble  in  DMSO
  • 保存條件: -20℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.558 ml 7.791 ml 15.583 ml
    5 mM 0.312 ml 1.558 ml 3.117 ml
    10 mM 0.156 ml 0.779 ml 1.558 ml
    50 mM 0.031 ml 0.156 ml 0.312 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶(hù)參考交流研究之用。
輸入產(chǎn)品批號(hào):

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學(xué)研究,銷(xiāo)售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷(xiāo)售條款。